{
  "id": 11677527,
  "title": "Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore",
  "url": "https://urgent.news/2026/10/03/aurobindo-pharma-receives-usfda-final-approval-for-perampanel-tablets",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-03T11:49:24.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/aurobindo-pharma-receives-usfda-final-approval-for-perampanel-tablets-market-size-estimated-at-558-crore"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Aurobindo Pharma announced on October 3, 2026, that it has received final approval from the USFDA to manufacture and market Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Fycompa® Tablets from Catalyst Pharmaceuticals, Inc. Market Opportunity The estimated market size for Perampanel Tablets stood…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}